Official registry condition

Liver Cirrhosis peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Liver Cirrhosis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

1 profiles.

Registry update years

2016–2026 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles1

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Liver Cirrhosis unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00628160

PeptideScanner retained ClinicalTrials.gov record NCT00628160 at 2026-11-15T21:47:40.408Z. Its registry update date was 2016-02-24, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 24, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06256432

PeptideScanner retained ClinicalTrials.gov record NCT06256432 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 13, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07252401

PeptideScanner retained ClinicalTrials.gov record NCT07252401 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-08-27, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
August 27, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →